Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neurol Clin ; 35(2): 175-190, 2017 05.
Article in English | MEDLINE | ID: mdl-28410655

ABSTRACT

To date, Alzheimer disease drug candidates have produced negative results in human trials, and progress in moving new targets out of the laboratory and into trials has been slow. However, based on 3 decades of previous work, there is reason to hope that amyloid-based and other novel therapies will move at a faster pace toward successful clinical trials. This article highlights selected preclinical research topics that are rapidly advancing in the laboratory.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Apolipoproteins E/genetics , Inflammation/complications , tau Proteins/metabolism , Alzheimer Disease/pathology , Animals , Apolipoproteins E/metabolism , Brain/metabolism , Brain/pathology , Cholesterol/metabolism , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...